To improve access to high-quality HIV care in underserved regions of Western Washington (WA) State, we collaborated with the WA State Department of Health (DOH) and community partners to launch four satellite HIV clinics. Here, we describe this innovative clinical care model, present an estimate of costs, and evaluate patient care outcomes, including virologic suppression rates. To accomplish this, we assessed virologic suppression rates 12 months before and 12 months after the satellite clinics opened, comparing people living with HIV (PLWH) who enrolled in the satellite clinics versus all PLWH in the same regions who did not. We also determined virologic suppression rates in 2015 comparing satellite clinic versus non-satellite clinic patients and compared care quality indicators between the satellite clinics and the parent academic clinic. Results demonstrate that the change in virologic suppression rate 12 months before to 12 months after the satellite clinics opened was higher for patients who enrolled in the satellite clinics compared to all those in the same region who did not (18% versus 6%, p < 0.001). Virologic suppression in 2015 was significantly higher for satellite clinic than non-satellite clinic patients at three of four sites. Care quality indicators were met at a high level at the satellite clinics, comparable to the parent academic clinic. Overall, through community partnerships and WA DOH support, the satellite clinic program increased access to best practice HIV care and improved virologic suppression rates in difficult-to-reach areas. This model could be expanded to other regions with inadequate access to HIV practitioners, though financial support is necessary.
Introduction
The epidemic of HIV in the United States (US) is shifting more to non-metropolitan areas, where people living with HIV (PLWH) access healthcare less and have lower rates of retention in care and viral suppression (Nelson et al., 2016; Schafer et al., 2017; Uphold & Mkanta, 2005) . Many factors lead PLWH in less populated communities to seek care at long distances from home, including geographic isolation, provider discrimination, stigma, confidentiality concerns, financial constraints, and lack of confidence in local medical systems (Heckman et al., 1998; Mainous & Matheny, 1996; McKinney, 2002; Pellowski, 2013; Schur et al., 2002) . Insufficient access to mental health and addiction treatment services is common in these areas (Wood, 2008) . These barriers may lead to delayed receipt of new HIV treatments, fewer provider visits, higher likelihood of receiving care from a lowvolume HIV provider, and higher probability of AIDS diagnosis at baseline or progression to AIDS (Cohn et al., 2001; Lahey et al., 2007; Lopes, Eron, Mugavero, Miller, & Napravnik, 2017; Ohl et al., 2010; Ohl et al., 2013; Weissman et al., 2015; Wilson et al., 2011) . This, along with the predicted attrition of the HIV provider workforce and growing size of the population of PLWH, underscores the widening gap between HIV care capacity and patient demands and the need for innovative ways to improve access to high-quality HIV care, especially outside of major cities (Weiser et al., 2016) .
To help address HIV care disparities in Western Washington (WA) State and to improve HIV treatment outcomes in under-resourced areas, we launched a satellite clinic program in 2007. To establish the satellite clinics, we targeted areas of the state in which patients lacked local access to providers with HIV training, including rural and urban underserved regions. We developed partnerships with local community-based clinics or health districts, which provide the facility, support staff, supplies, and basic equipment for the clinic sessions. Clinical HIV specialists from our academic medical center (Harborview Medical Center, a component of University of Washington Hospitals) travel to the community sites weekly or biweekly to deliver direct patient care. The Washington State Department of Health (WA DOH) provides funding to both Harborview Medical Center and three of the four local community partners to support the program.
Here, we describe this innovative clinical care model and present patient care outcomes, including virologic suppression rates and other quality of care indicators, and illustrate challenges we encountered plus solutions we devised in order to sustain the program. The goal is to inform other regions and institutions that struggle to deliver care to PLWH outside major cities.
Methods
For the purpose of describing the satellite clinics, we use the term "rural" to describe a city with population below 50,000, "urban" as population 50,000 to 499,999, and "metropolitan" as above 500,000 (Nelson et al., 2016) . Population figures are based on 2014 US Census data (United States Census Bureau, 2014). Descriptions of the satellite clinic patient population, such as the number who were previously out of care or who previously drove long distances to care, come from a one-time survey administered to all PLWH who enroll at one of the satellite clinics at their first visit to that clinic.
For the analysis, we assessed the patient and community-level impact of the satellite clinic system through three methods: (1) an assessment of HIV RNA (viral load, VL) suppression rates one year before and one year after each clinic opened, comparing PLWH who attended each satellite clinic to all PLWH living in the same region who did not attend the satellite clinics, (2) a snapshot of the proportion of PLWH with VL suppression in 2015 comparing those in each region who attended the satellite clinics versus those who did not, and (3) a comparison of quality of care indicators, including performance on various HIV primary care-related clinical measures at the satellite clinics versus at the academic clinic in Seattle (Harborview Medical Center's HIV Clinic, also known as Madison Clinic and hereafter referred to as Madison Clinic).
For the first objective, an assessment of VL suppression rates before and after each satellite clinic opened, we identified satellite clinic patients from our electronic medical record with documented medical visits within 12 months of the date when each satellite clinic opened. Using the state HIV surveillance registry, the Enhanced HIV/AIDS Reporting System (eHARS), we evaluated the proportion of these patients with virologic suppression (at or below 200 copies/mL), using the last VL within the 12 months before and 12 months after the clinics opened. As a comparison group, we used the eHARS registry to identify all PLWH residing in the same regions who did not attend the Madison satellite clinics and evaluated VL suppression using measurements from the same timeframes. We defined the region as the same county for three of the satellite clinics and as the same city for the Federal Way clinic (because the Federal Way clinic lies in King County, which also includes the city of Seattle, where Madison Clinic is located). Both satellite and non-satellite clinic patient groups were limited to individuals who were diagnosed at least 12 months before the clinics opened in order to exclude newly-diagnosed patients who may not yet be taking ART. We calculated the difference in these proportions of VL suppression (12 months before and 12 months after clinic opening) for the two groups using the 2-sample Chi-squared test. Surveillance data for this analysis and subsequent objectives were based on cases and laboratory results reported to WA DOH as of 31 August 2016.
For the second objective, a snapshot of VL suppression rates, we identified satellite clinic patients who had at least one documented clinic visit in 2015. Using eHARS, we evaluated the proportion of these patients with VL suppression (HIV RNA below 200 copies/mL) compared to all PLWH in the same region who were not satellite clinic patients. Both groups were limited to individuals diagnosed before 1 January 2015. We compared the proportion of VL suppression between these groups, as well as baseline characteristics, using the Chi-squared test.
For the third objective, an evaluation of clinical quality of care indicators, we compared satellite clinic patients to those followed at the parent Madison Clinic in Seattle. Because we did not have access to full clinical data for non-Madison patients in the satellite clinic regions, we did not include that group in this comparison. For Madison satellite patients and Madison patients in Seattle, we assessed the proportion who received or achieved the following healthcare indicators: prescription of antiretroviral therapy (ART), VL suppression (HIV RNA below 200 copies/mL), lipid screening, hepatitis B virus (HBV) and hepatitis C virus (HCV) serologic testing, HBV vaccination (for anti-HBV surface antibody-negative persons), tetanus-diptheria-pertussis (TDaP) vaccination, and pneumococcal vaccination.
We evaluated these outcomes among those patients who attended two or more medical visits within an 18-month time period (1 January 2015 to 30 June 2016) at one of the satellite clinics or at Madison Clinic. To examine retention in care, we identified individuals with at least one provider visit in the first six-month period (1 January 2015 to 30 June 2015) and considered them to be retained in care if they had a subsequent visit within the next 12 months (1 July 2015 to 30 June 2016).
Finally, to provide a description of program costs, we reviewed expenses and revenue for one of the satellite clinics (Bremerton, Kitsap County) for one fiscal year (2015 to 2016) and summarized these budget figures.
This study was considered minimal risk and thus exempt from IRB review.
Results
To date, we have established four satellite clinics by partnering with distinct partners (Figure 1 Since the satellite clinics started, 694 patients have enrolled and completed 5162 visits (as of 12/31/2015). Enrollment increased steadily in the years since each clinic was established (Figure 2 ). Based on patient survey data (completed by 477 patients; response rate 69%), as of 1 July 2016 the satellite clinic attendees included 28 patients who had never previously sought care for HIV infection and 58 patients who had been out of care for more than 12 months. Thirty-nine newly diagnosed patients were linked to care at one of the satellite clinics. Travel distance was reduced for 125 patients to less than 25 miles, including for 64 patients who had previously traveled greater than 50 miles to receive care.
Demographic data for satellite clinic patients as compared to non-satellite clinic patients living in the same regions, pooled for the four counties in 2015, are presented in Table 1 . Satellite and non-satellite patients were comparable in gender, age, race/ethnicity, and CD4 counts (the difference in race/ethnicity met criteria for statistical significance, but the absolute difference between the categories of race/ethnicity were small). A higher prevalence of satellite clinic patients reported a history of injection drug use compared with non-satellite clinic patients (25% versus 15%).
Collectively, at 12 months prior to each of the satellite clinics opening, the proportion of PLWH with VL at or below 200 copies/mL was 59% for those who enrolled in the satellite clinics versus 46% for those in the same regions who did not enroll; 12 months after the launch of the satellite clinics, the proportion with VL suppression increased to 77% versus 52%, respectively (net change in rates of VL suppression 18% for PLWH who enrolled in the satellite clinics versus 6% for those who did not; p < 0.001 by Chi-Square test; Figure 3) .
A snapshot of VL suppression rates in 2015 comparing PLWH in each region who attended the satellite clinics versus those who did not showed the following rates of VL suppression: 89% versus 60% for Bremerton (p < 0.001), 93% versus 74% for Everett (p < 0.001), 76% versus 68% for Olympia (p = 0.44), and 89% versus 79% for Federal Way (p = 0.017; Figure 4) .
Among PLWH who attended two or more medical visits within an 18-month time period (1 January 2015 to 30 June 2016) at one of the satellite clinics or at Madison Clinic, the proportion who met a variety of quality of care indicators including immunization and screening was similar for patients attending the satellite clinics and those attending the parent academic clinic in Seattle ( Table 2) .
The primary costs incurred by the University of Washington and Harborview Medical Center for operating the satellite clinics are the costs of salaries and benefits for providers and support staff. The principal source of revenue is financial support from WA DOH. A financial summary of one clinic demonstrates that costs would not be covered without this financial support (Table 3 ).
Discussion
One of the US National HIV/AIDS Strategy goals is to increase the percentage of PLWH with virologic suppression to over 80% in all regions (National HIV/ AIDS Strategy for the United States: Updated to 2020 2015). To accomplish this, access to comprehensive care and well-trained providers must be a priority, including for PLWH living outside major cities. Here, we present a description and evaluation of a program that extends HIV care to rural and urban-underserved regions in Western WA via academic satellite clinics, one of the first programs of its kind documented in a developed country. Our principal findings are that: (1) partnership between an academic medical center and multiple community entities, with fiscal support from a state department of health, reduced geographic barriers to care, (2) implementation of a decentralized clinic system led to improved virologic suppression rates in under-resourced regions of the state, and (3) quality of care at the remote clinics is high and comparable to the metropolitan academic HIV clinic. These findings have implications for systems of HIV care on a large scale. Nationally, linkage to and retention in care are two principal challenges in HIV medicine. Improving these measures would lead to higher treatment and VL suppression rates and could dramatically decrease HIV transmissions, deaths, and costs of care (Sabin et al., 2017; Shah, Risher, Berry, & Dowdy, 2016) . A recent US-based study reported that retention in care and VL suppression rates are significantly lower in rural and urban areas compared to metropolitan areas (Nelson et al., 2016) . Furthermore, rising numbers of PLWH are living in non-metropolitan areas (Schafer et al., 2017) . Our findings suggest that a sustainable satellite clinic system that brings HIV expertise to nonmetropolitan communities significantly improves VL suppression rates. We found improvement in the proportion with VL suppression by 12 months after the satellite clinics opened and a significantly higher proportion with VL suppression in a 2015 snapshot for those PLWH who were engaged at the satellite clinics as compared with PLWH in the same regions who were not. Viral suppression rates were above US National HIV/AIDS Strategy and CDC 2015 goals (80% or higher) at three of four satellite clinics, whereas rates in the same counties for PLWH not engaged with the satellite clinics fell below this goal in every region. The proportion of PLWH retained in care at the satellite clinics also exceeded national targets (Centers for Disease Control Figure 3 . Viral load suppression 12 months pre and 12 months post satellite clinic launch, comparing PLWH who enrolled at the satellite clinics to all those PLWH in the same regions who did not (net change in proportion with VL suppression 18% for patients who enrolled in the satellite clinics versus 6% for those who did not; p < 0.001 by Chi-Square test). We attribute the success of the satellite clinic program to the delivery of care to the communities where patients reside, thus overcoming geographic isolation and transportation barriers. For example, prior to the Bremerton clinic opening, patients in that region had to travel to Bremerton, catch a ferry to Seattle, make their way to the county hospital, and then complete the return trip -a costly journey that took many hours. We have also learned that the success of our program relies heavily on close relationships with community partners and establishing a secure funding mechanism. Our analysis demonstrates that clinical revenues from the satellite clinic system are not self-sustaining and the program would not be viable without close collaboration and financial support from the state DOH.
Our satellite HIV clinics have faced a number of challenges since their inception. Some of the most significant hurdles involved integrating into the local communities and developing an efficient means for obtaining local referrals and procedures, including radiologic imaging (which is unavailable at three of four satellite clinics), coordinating local hospitalizations, and addressing urgent care needs on days when the clinics were not in session. Access to local mental health resources in these regions is difficult. Furthermore, the rapid growth of the satellite clinics led to extended wait times for provider visits, and the need for preventive services for partners and other HIV-uninfected at-risk individuals quickly became evident. Additionally, the clinics utilize a variety of electronic health record (EHR) systems and some have their own credentialing processes.
We addressed these challenges in a number of ways. We collaborated with local primary care providers (PCP's) who helped care for patients on days when the satellite clinics were not in session. To handle increased demand, we added a second HIV specialist provider two days per month and a medical assistant weekly at two of the satellite clinics. We opened all of the clinics to partner and preventive services, including HIV testing and pre-exposure prophylaxis (PrEP), and we worked closely with local case managers to coordinate referrals. We also developed a plan to institute tele-psychiatry consultations for one of the satellite clinics where access to mental health resources is especially problematic. Finally, we collaborated with local partners at each of the non-University of Washington network clinics to make a plan that would allow for patient documentation to occur in the Harborview EHR and also remain visible in the local EHR. An added benefit of the satellite clinic system has been enhanced educational opportunities for students and trainees. Medical students and residents now accompany faculty to the satellite clinics regularly and experience the inherent differences of providing HIV primary care in community-based settings versus at a large academic medical center.
The satellite clinic model has limitations. There is a geographic limitation based on feasible travel for providers. We feel this satellite clinic model could be effectively combined with provider-to-patient telemedicine visits to extend the reach and benefits and we are exploring this option. Another ongoing need is improving the capacity of local providers to deliver quality HIV preventive and treatment services. We have given trainings related to HIV care and prevention to staff at the satellite clinic sites, distributed resources related to PrEP, and supported PrEP initiation by PCP's. In this way, connections made at the satellite clinics have helped to increase capacity of local providers. We also believe the satellite clinic model is complemented well by programs that support care capacity through longitudinal distance mentoring of community practitioners, such as Project ECHO (a telehealth Abbreviations: ART = antiretroviral therapy; TDaP = tetanus-diptheria-pertussis; PCV-13 = 13-valent pneumococcal conjugate vaccine; PPSV-23 = 23-valent pneumococcal polysaccharide vaccine; IU = international units. program that creates virtual communities of practice for providers across broad regions). Through collaborations at the satellite clinic sites, we have helped multiple PCP's and other staff members enroll in our HIV and hepatitis C Project ECHO programs (Scott et al., 2012; Wood et al., 2016) . Limitations of this study include the cross-sectional nature and reliance on surveillance data, which may have missing information and may misrepresent where PLWH resided within a given time period. The analysis may not fully account for unmeasured confounders. For the quality of care metrics, some values may be underestimates, especially for satellite clinic patients, who may have received vaccines or other measures from outside providers. Additionally, while we were able to summarize cost and revenue, we were not able to assess value for money or cost effectiveness (Drummond, 2005) .
In summary, while specialized care is often localized to metropolitan hubs, we found that a satellite clinic system can reach PLWH in underserved areas and affect clinically important outcomes. While much has been studied about decentralized care in resource-limited countries, data for programs to address disparities in care in better-resourced nations are scant. Given recent data showing increased proportions of PLWH residing in less-populated areas, worse outcomes along the continuum of care in rural regions, plus recent HIV outbreaks in rural parts of the US, these findings are especially noteworthy. This model could be replicated and expanded in other regions that struggle to provide HIV care to under-resourced communities.
